Following reports of Johnson & Johnson selling their diabetes division, Roche has announced plans to expand and innovate their diabetes business. This innovation comes with plans to partner with smaller companies to offer more device options. Roland Digglemann, head of diagnostics, said in interview with Reuters, “We’re looking around: Are there new possibilities, are there alternatives?” An emerging market for Roche, as of late, has come from China, where an estimated 100 million people may be living with diabetes. Read the full article here.
